Use of Non-pharmacological Therapies in Individuals With Migraine Eligible for Treatment With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Signaling: A Single-Center Cross-Sectional Observational Study

INTRODUCTION: Accessibility of treatment with monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) signaling pathway is impeded by regulatory restrictions. Affected individuals may seek out other services including non-pharmacological therapies. Thus, we found it timely to asce...

Descripción completa

Detalles Bibliográficos
Autores principales: Rundblad, Lucas, Cullum, Christopher Kjaer, Sacco, Simona, Gil-Gouveia, Raquel, Uludüz, Derya, Do, Thien Phu, Amin, Faisal Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pain Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326044/
https://www.ncbi.nlm.nih.gov/pubmed/35910264
http://dx.doi.org/10.3389/fpain.2022.935183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326044/
https://www.ncbi.nlm.nih.gov/pubmed/35910264
http://dx.doi.org/10.3389/fpain.2022.935183

Ejemplares similares